Literature DB >> 16803462

Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.

P Amerio1, M Tracanna, P De Remigis, C Betterle, L Vianale, M E Marra, D Di Rollo, R Capizzi, C Feliciani, A Tulli.   

Abstract

Vitiligo is a common skin disease characterized by depigmented maculae resulting from a reduction of the number and function of melanocytes. Many studies suggest that vitiligo might be an autoimmune disease. Vitiligo has been frequently described in association with other autoimmune diseases. Among the diseases described in association with vitiligo are the so-called autoimmune polyglandular syndromes (APS). Vitiligo can be present in all types of APS but the most frequent association appears to be in APS-3. APS-3 was defined as the association between autoimmune thyroiditis and another autoimmune disease. Here we report one patient with thyroiditis, vitiligo and autoimmune gastritis (APS-3B+C), one patient with chronic autoimmune thyroiditis, vitiligo and alopecia (APS-3C), and one case of a young patient with type 1 diabetes mellitus and vitiligo (APS-4), according to the newest classification. We stress the importance of a thorough assessment for autoimmune diseases in selected patients with vitiligo.

Entities:  

Mesh:

Year:  2006        PMID: 16803462     DOI: 10.1111/j.1365-2230.2006.02171.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Unexplained refractory iron-deficiency anaemia in a 41-year-old woman.

Authors:  N de Matthaeis; G L Rapaccini; L Riccardi; D Pugliese
Journal:  BMJ Case Rep       Date:  2010-08-19

Review 2.  Autoimmune gastritis: Pathologist's viewpoint.

Authors:  Irene Coati; Matteo Fassan; Fabio Farinati; David Y Graham; Robert M Genta; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Vitiligo, hypothyroidism and cardiomyopathy.

Authors:  Yashdeep Gupta; Ariachery C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2012-05

Review 4.  Autoimmune atrophic gastritis: current perspectives.

Authors:  Artem Minalyan; Jihane N Benhammou; Aida Artashesyan; Michael S Lewis; Joseph R Pisegna
Journal:  Clin Exp Gastroenterol       Date:  2017-02-07

Review 5.  Autoimmune diseases in autoimmune atrophic gastritis.

Authors:  Kryssia Isabel Rodriguez-Castro; Marilisa Franceschi; Chiara Miraglia; Michele Russo; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

6.  Alopecia Areata Universalis in the Onset of Autoimmune Polyendocrine Syndrome Type III C.

Authors:  Nicoleta Neagu; Silviu Horia Morariu; Alina Grama
Journal:  Int J Trichology       Date:  2022-04-04

7.  Serum Thyroid Hormone Antibodies Are Frequent in Patients with Polyglandular Autoimmune Syndrome Type 3, Particularly in Those Who Require Thyroxine Treatment.

Authors:  Roberto Vita; Maria Giulia Santaguida; Camilla Virili; Maria Segni; Marina Galletti; Mattia Mandolfino; Flavia Di Bari; Marco Centanni; Salvatore Benvenga
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-28       Impact factor: 5.555

8.  Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario.

Authors:  Oriol Calvete; José Reyes; Hernán Valdés-Socin; Paloma Martin; Mónica Marazuela; Alicia Barroso; Javier Escalada; Antoni Castells; Raúl Torres-Ruiz; Sandra Rodríguez-Perales; María Currás-Freixes; Javier Benítez
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.